Hubei Jumpcan Pharmaceutical Co.,Ltd.’s Net Profit Rose 16.6% in First Quarter of 2023

Hubei Jumpcan Pharmaceutical Co.,Ltd. (湖北济川药业股份有限公司) (600566.SH) reported a net profit of 678.2 million yuan in the first quarter of 2023, up 16.6% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 9.9% year-on-year.

At the end of the reporting period, it had 15.8 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 23.7%.